Abstract
Significant research efforts have been concerned over the past few years to design carrier systems that could specifically deliver active agents to the tumor sites, with the purposes of maximizing the therapeutic benefits and minimizing the toxic side-effects. Hyaluronic acid is a type of polysaccharide that has been extensively studied as a selective targeting ligand to cancerous cells that overexpress its specific receptor CD44. The aim of this review is to highlight the role of HA in cancer, focusing on the recent advances of HA-functionalized lipid nanoparticles towards cancer therapy and imaging.
Keywords: Cancer targeting, CD44 receptors, Hyaluronic acid, Lipid nanoparticles, tumor, polysaccharide.
Current Pharmaceutical Design
Title:Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting
Volume: 23 Issue: 35
Author(s): May S. Freag*
Affiliation:
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521,Egypt
Keywords: Cancer targeting, CD44 receptors, Hyaluronic acid, Lipid nanoparticles, tumor, polysaccharide.
Abstract: Significant research efforts have been concerned over the past few years to design carrier systems that could specifically deliver active agents to the tumor sites, with the purposes of maximizing the therapeutic benefits and minimizing the toxic side-effects. Hyaluronic acid is a type of polysaccharide that has been extensively studied as a selective targeting ligand to cancerous cells that overexpress its specific receptor CD44. The aim of this review is to highlight the role of HA in cancer, focusing on the recent advances of HA-functionalized lipid nanoparticles towards cancer therapy and imaging.
Export Options
About this article
Cite this article as:
Freag S. May*, Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting, Current Pharmaceutical Design 2017; 23 (35) . https://dx.doi.org/10.2174/1381612823666170526103015
DOI https://dx.doi.org/10.2174/1381612823666170526103015 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance
Current Medicinal Chemistry Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways
CNS & Neurological Disorders - Drug Targets Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Preliminary Study of microRNAs Allele-specific Targeting in Allergic Rhinitis Patients from Central China
Combinatorial Chemistry & High Throughput Screening A2B Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Computational and Experimental Studies on Human Misshapen / NIK- Related Kinase MINK-1
Current Medicinal Chemistry Vital Tooth Whitening Techniques. A Literature Review
Current Dentistry The Antibiotic Effects of Vitamin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Non Peptidic αvβ3 Antagonists: Recent Developments
Current Medicinal Chemistry Evaluation of Cell-free Expression System for the Production of Soluble and Functional Human GPCR N-formyl Peptide Receptors
Protein & Peptide Letters MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
Current Alzheimer Research Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity
Current Topics in Medicinal Chemistry Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation Interleukin-10: An Anti-Inflammatory and Immunosuppressive Cytokine in the Normal and Pathological Immune Response
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Aptamers: Molecular Tools for Medical Diagnosis
Current Topics in Medicinal Chemistry Pharmacological Properties of Physical Exercise in The Elderly
Current Pharmaceutical Design